Peripheral neuropathy in transgenic diabetic mice: Restoration of C- fiber function with human recombinant nerve growth factor

Diabetes

Volumn 47, Issue 10, 1998, Pages 1637-1642

  Elias, Kathleen A ^a   Cronin, Michael J ^a   Stewart, Timothy A ^a   Carlsen, Richard C ^b  

^a GENENTECH INC   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RECOMBINANT NERVE GROWTH FACTOR;

ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; MOUSE; NERVE CONDUCTION; NERVE FIBER C; NONHUMAN; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; SCIATIC NERVE; SUBCUTANEOUS DRUG ADMINISTRATION; SURAL NERVE; TIBIAL NERVE; TRANSGENIC MOUSE;

ANIMALS; BLOOD GLUCOSE; DIABETIC NEUROPATHIES; ELECTRIC STIMULATION; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; INSULIN; ISLETS OF LANGERHANS; MALE; MICE; MICE, TRANSGENIC; NERVE FIBERS; NERVE GROWTH FACTORS; NEURAL CONDUCTION; RECOMBINANT PROTEINS; SCIATIC NERVE;

EID: 0031695432     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.47.10.1637     Document Type: Article

References (35)

1. Thomas PK, Tomlinson DR: Diabetic and hypoglycemic neuropathy. In Peripheral Neuropathy. Dyck PJ, Thomas PK, Eds. Philadelphia, W.B. Saunders, 1993, p. 1219-1250
2. Brown MJ, Ashbury AK: Diabetic neuropathy. Ann Neurol 15:2-12, 1984
3. Greene DA, Sima AAF, Stevens MJ, Feldman EL, Lattimer SA: Complications: neuropathy, pathogenetic considerations. Diabetes Care 15:1902-1925, 1992
4. Ebendal T: Function and evolution in the NGF family and its receptors. J Neurosci Res 32:461-470, 1992
5. Levi-Montalcini R, Dal Toso R, della Valle F, Skaper SD, Leon A: Update of the NGF saga. J Neurol Sci 130:119-127, 1995
6. Faradji V, Soleto J: Low serum levels of nerve growth factor in diabetic neuropathy. Acta Neurol Scand 81:402-406, 1990
7. Hellweg R, Hartung HD: Endogenous levels of nerve growth factor (NGF) are altered in experimental diabetes mellitus: a possible role for NGF in the pathogenesis of diabetic neuropathy. J Neurosci Res 26:258-267, 1990
8. Hellweg R, Wohrle M, Hartung HD, Stracke H, Hock C, Federlin K: Diabetes mellitus-associated decrease in nerve growth factor levels is reversed by allogenic pancreatic islet transplantation. Neurosci Lett 125:1-4, 1991
9. Hanaoka Y, Ohi T, Furukawa S, Hayashi K, Matsukura S: Effect of 4-methylcatechol on sciatic nerve growth factor level and motor nerve conduction velocity in experimental diabetic neuropathic process in rats. Exp Neurol 115:292-296, 1992
10. Jakobsen J, Brimijoin S, Skau K, Sidenius P, Wells D: Retrograde axonal transport of transmitter enzymes, fructose-labeled protein, and nerve growth factor in streptozotocin-diabetic rats. Diabetes 30:797-803, 1981
11. 12I] nerve growth factor in ileal mesenteric nerves in vitro: effect of streptozotocin diabetes. Brain Res 378:325-336, 1986
12. Willars GB, Calcutt NA, Compton AM, Tomlinson DR: Substance P levels in peripheral nerve, skin, atrial myocardium and gastrointestinal tract of rats with long-term diabetes mellitus. J Neurol Sci 91:153-164, 1989
13. Diemel LT, Stevens EJ, Willars GB, Tomlinson DR: Depletion of substance P and calcitonin gene-related peptide in sciatic nerve of rats with experimental diabetes: effects of insulin and aldose reductase inhibition. Neurosci Lett 137:253-256, 1992
14. Diemel LT, Brewster WJ, Fernyhough P, Tomlinson DR: Expression of neuropeptides in experimental diabetes: effects of treatment with nerve growth factor or brain-derived neurotrophic factor. Mol Brain Res 21:171-175, 1994
15. Apfel SC, Azezzo JC, Brownlee M, Federoff H, Kessler JA: Nerve growth factor administration protects against experimental diabetic sensory neuropathy. Brain Res 634:7-12, 1994
16. Martin L, Keller GA, Liggitt D, Oakley H, Pitts-Meek SL, Seigel MW, Terrell T, Stewart TA: Male-specific B-cell dysfunction and diabetes resulting from increased expression of a syngeneic MHC Class I protein in the pancreata of transgenic mice. New Biologist 2:1101-1110, 1990
17. Diemel LT, Ferrnyhough P, Mohiuddin L, Brewster WJ, Maeda K, Tomlinson DR: NGF treatment normalizes sciatic nerve neuropeptide deficits in diabetic rats without affecting motor conduction or laser Doppler flux (Abstract). 3rd Int Symp Diabetic Neuropathy (Japan). 1994, abstract 17, p. 29
18. Verge VMK, Merlio J-P, Grondin J, Ernfors P, Persson H, Riopelle RJ, Hokfelt T, Richardson PM: Colocalization of NGF binding sites, trk mRNA, and low- affinity NGF receptor mRNA in primary sensory neurons: responses to injury and infusion of NGF. J Neurosci 12:4011-4022, 1992
19. Stanley EF: Sensory and motor nerve conduction velocities and the latency of the H reflex during growth of the rat. Exp Neurol 71:497-506, 1981
20. In Statistical Principles in Experimental Design. 2nd ed. Winer BJ, Ed. New York, McGraw-Hill, 1971
21. Yagihashi S: In Frontiers in Diabetic Research: Lessons From Animal Diabetes. Vol 3. Shafrir E, Ed. London, Smith-Gordon, 1991, p. 459-463
22. Apfel SC, Lipton RB, Azezzo JC, Kessler JA: Nerve growth factor prevents toxic neuropathy in mice. Annals of Neurology 29:87-90, 1991
23. Apfel SC, Azezzo JC, Lipton RB, Kessler JA: Nerve growth factor prevents experimental cisplatin neuropathy. Ann Neurol 31:76-80, 1992
24. Cronin M, Soriano R, Lyon R: Recombinant human nerve growth factor protects against cisplatin proprioceptive defect in mice (Abstract). FASEB J 6:A1916, 1992
25. Levi-Montalcini R: The nerve growth factor 35 years later. Science 237:1154-1162, 1987
26. Linsay RM, Harmar AJ: Nerve growth factor regulates expression of neuropeptide genes in adult sensory neurons. Nature 337:362-364, 1989
27. Wong J, Oblinger MM: NGF rescues substance P expression but not neurofilament or tubulin gene expression in axotomized sensory neurons. J Neurosci 11:543-552, 1991
28. Smeyne RJ, Klein R, Schnapp A, Long LK, Bryant S, Lewin A, Lira SA, Barbacid M: Severe sensory and sympathetic neuropathies in mice carrying a disrupted Trk/NGF receptor gene. Nature 368:246-249, 1994
29. Crowley C, Spencer SD, Nishimura MC, Chen KS, Pitts-Meek S, Armanini MP, Ling LH, McMahon SB, Shelton DL, Levinson AD, Phillips HS: Mice lacking nerve growth factor display perinatal loss of sensory and sympathetic neurons yet develop basal forebrain cholinergic neurons. Cell 76:1001-1011, 1994
30. Snider WD: Functions of the neurotrophins during nervous system development: what the knockouts are teaching us. Cell 77:627-638, 1994
31. Windebank AJ, Blexnid MD: Biological activity of a new neuronal growth factor from injured peripheral nerve. Dev Brain Res 49:243-251, 1989
32. McMahon SB, Armanini MP, Ling LH, Phillips HS: Expression and coexpression of Trk receptors in subpopulations of adult primary sensory neurons projecting to identified peripheral targets. Neuron 12:1161-1171, 1994
33. Verge VM, Richardson PM, Benoit R, Riopelle RJ: Histochemical characterization of sensory neurons with high-affinity receptors for nerve growth factor. J Neurocytol 18:583-591, 1989
34. Tomlinson DR, Fernyhough P, Diemel LT: Role of neurotrophins in diabetic neuropathy and treatment with nerve growth factors. Diabetes (Suppl. 1) 46:S43-S49, 1997
35. Apfel SC, Kessler JA, Adomato BT, Litchy WJ, Sanders C, Rask CA: A randomized double-blind, placebo controlled trial of recombinant human nerve growth factor in symptomatic diabetic polyneuropathy with small fiber sensory loss. Neurology 51:1-8, 1998